J Korean Ophthalmol Soc.  2005 Mar;46(3):396-401.

Treatment of Exposed Hydroxyapatite Orbital Implant Using Acellular Dermal Allograft

• La TY
• Park JW

Abstract

PURPOSE
To investigate the results of acellular dermal allograft (SureDerm(R), Hans Biomed Co., Korea) as a new covering material in the exposure of hydroxyapatite orbital implant. METHODS: SureDerm graft was performed in 5 patients with exposed hydroxyapatite orbital implant. Under local anesthesia, the anterior surface of the exposed implant was trimmed and the designed SureDerm was sutured at the margin of the sclera with 6-0 Vicryl. Finally, conjunctival suture was done. The patients were followed up regularly until postoperative 10 months. RESULTS: The average diameter of exposed implant was 9.6 X 9.0 mm. The grafted SureDerm had survived in all patients at postoperative 10 months and exposure of implant was treated successfully in all cases. CONCLUSIONS: We consider that acellular dermal allograft will be a good replacing material when preserved sclera is not available. It also features the advantage of avoiding the intricate harvesting procedure and the scarring of the donor site in dermo-fat graft.

Keyword

Acellular dermal allograft; Exposure of hydroxyapatite orbital implant

MeSH Terms

Allografts*
Anesthesia, Local
Cicatrix
Durapatite*
Humans
Orbit*
Orbital Implants*
Polyglactin 910
Sclera
Sutures
Tissue Donors
Transplants
Durapatite
Polyglactin 910